These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 30144)
1. [Histamine H2 receptor antagonists in gastroduodenal pathology]. Puşcaş I Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):299-304. PubMed ID: 30144 [No Abstract] [Full Text] [Related]
2. [Current antihistaminic preparations in treatment of peptic ulcer (review of foreign literature)]. Ryss ES Klin Med (Mosk); 1978 Jun; 56(6):17-24. PubMed ID: 27666 [No Abstract] [Full Text] [Related]
3. Histamine H2-receptor antagonists in the treatment of duodenal ulcers. Bank S; Barbezat GO; Novis BH; Tim LO; Odes HS; Helman C; Narunsky L; Duys PJ; Marks IN S Afr Med J; 1976 Oct; 50(44):1781-5. PubMed ID: 11564 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of peptic ulcer with histamine H2 receptor antagonists]. Domschke W; Domschke S; Demling L Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347 [TBL] [Abstract][Full Text] [Related]
6. [New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature)]. Ionov ID Farmakol Toksikol; 1978; 41(5):624-32. PubMed ID: 81139 [No Abstract] [Full Text] [Related]
7. [Cimetidine and other H2 receptor blockers]. Pavlotzky M; Eschchar I; Neuman M Harefuah; 1978 Oct; 95(7):219-23. PubMed ID: 31319 [No Abstract] [Full Text] [Related]
8. Effect of the H2-receptor antagonists (burimamide and metiamide) on gastric secretion stimulated by histamine and its methyl derivatives. Preiss DU; Code CF J Pharmacol Exp Ther; 1975 May; 193(2):614-20. PubMed ID: 238026 [TBL] [Abstract][Full Text] [Related]
9. [Cimetidine and recent H2-receptor blocking agents in the therapy of gastrointestinal diseases]. Gugler R; Musch E Med Welt; 1982 Aug; 33(31-32):1083-86. PubMed ID: 6127590 [No Abstract] [Full Text] [Related]
10. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome. Lamers CB; Festen HP; van Tongeren JH Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379 [TBL] [Abstract][Full Text] [Related]
12. [Action of histamine H2 receptor blockaders on gastric motor function in duodenal peptic ulcer]. Shcherbak VV; Glubochenko VG; Zaĭdman VE Klin Med (Mosk); 1984 Jun; 62(6):94-6. PubMed ID: 6147438 [No Abstract] [Full Text] [Related]
13. The effect of metoclopramide on human gastric emptying and secretion. Meeroff JC Acta Gastroenterol Latinoam; 1974; 6(2):55-61. PubMed ID: 4618972 [No Abstract] [Full Text] [Related]
15. Interactions between histaminergic and cholinergic pathways of gastric motility regulation. Milenov K; Todorov S; Vassileva M; Zamfirova R; Shahbazian A Methods Find Exp Clin Pharmacol; 1996; 18(1):33-9. PubMed ID: 8721254 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the tumor inhibiting effects of three histamine H2-receptor antagonists. Tutton PJ; Barkla DH Anticancer Res; 1983; 3(1):7-10. PubMed ID: 6131640 [TBL] [Abstract][Full Text] [Related]
17. Proceedings: Inhibition of nocturnal acid secretion in duodenal ulcer by oral metiamide. Williams JG; Milton-Thompson GJ; Jenkins DJ; Misiewicz JJ Gut; 1974 Apr; 15(4):337. PubMed ID: 4151865 [No Abstract] [Full Text] [Related]
18. [A new H2-receptor antagonist in the treatment of gastrointestinal diseases]. Senfft U Med Welt; 1982 Oct; 33(43):1516-8. PubMed ID: 6130463 [No Abstract] [Full Text] [Related]